Pamisell ranked among the top searched stocks for 13 days in the past month.

As of 9:30 AM on the 19th, Pamisell is trading at 21,500 KRW, up 0.23% from the previous day. This is an 8.9% decrease compared to August 6. Pamisell is known as a bio-pharmaceutical company that developed the world's first stem cell therapy.

Over the past five days, individual investors have sold a net 348,286 shares, while foreigners and institutions have bought a net 299,917 shares and 24,281 shares, respectively.

※Source: AI Investment Assistant AI Lassi

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing